［1］Siegel R，Naishadham D，Jemal A.Cancer statistics，2013［J］.CA Cancer J Chin,2013，63(1)：11-30.
［2］Xue LF，Sun PM，Xiang SW.Advances in the study of the relationship between miRNA and the occurrence and development of endometrial carcinoma［J］.Chin J Clin Obst Gynecol，2015，16(1)：91-93.［薛丽芳，孙蓬明，项双卫.miRNA与子宫内膜癌发生发展预后相关性的研究进展［J］.中国妇产科临床杂志，2015，16(1)：91-93.］
［3］Liu C，Yu J，Yu S，et al.MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma［J］.J Hepatol，2010，53(1)：98-107.
［4］Shi S，Yu L，Chiu C，et al.Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis［J］.J Am Soc Nephrol，2008，19(11)：2159-2169.
［5］Lee SO，Masyuk T，Splinter P，et al.MicroRNA-15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease［J］.J Clin Invest，2008，118(11)：3714-3724.
［6］Fareh M，Turchi L，Virolle V，et al.The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network［J］.Cell Death Differ，2012，19(2)：232-244.
［7］Zhu K，Pan Q，Jia LQ，et al.miR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells［J］.Sci Rep，2014，4：5524.
［8］Greco SJ，Rameshwar P.MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell derived neuronal cells［J］.Proc Natl Acad Sci USA，2007，104(39)：15484-15489.
［9］Kalogiannidis I，Agorastos T.Conservative management of young patients with endometrial highly-differentiated adenocarcinoma［J］.J Obstet Gynaecol，2011，31(1)：13-17.
［10］Ren YL，Wang HY，Shi DR，et al.Combined treatment and prognostic factors for stage III and IV endometrial carcinoma［J］.Chin J Obst Gynecol，2008，43(7)：523-527.［任玉兰，王华英，施达仁，等.晚期子宫内膜癌患者的治疗及预后分析［J］.中华妇产科杂志，2008，43(7)：523-527.］
［11］Esquela-Kerscher A，Slack FJ.Oncomirs-microRNAs with a role in cancer［J］.Nat Rev Cancer，2006，6(4)：259-269.
［12］Calin GA，Sevignani C，Dumitru CD，et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers［J］.Proc Natl Sci USA，2004，101(9)：2999-3004.
［13］Feng Q，Lei Z，Lu HD.The study of relationship between miRNA and tumor［J］.Chin J Clini(Electronic Edition)，2012，6(15)：4390-4393.［冯琼，雷章，卢宏达.miRNA与肿瘤关系的研究［J］.中华临床医师杂志(电子版)，2012，6(15)：4390-4393.］
［14］Barroso-Del Jesus A，Lucena-Aguilar G，Menendez P.The miR-302-367 cluster as a potential stemness regulator in ESCs［J］.Cell Cycle，2009，8(3)：394-398.
［15］Lin SL，Chang DC，Chang-Lin S，et al.miR-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state［J］.RNA，2008，14(10)：2115-2124.
［16］Lin SL，Chang DC，Ying SY，et al.MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways［J］.Cancer Res，2010，70(22)：9473-9482.
［17］Yan GJ，Yu F，Wang B，et al.MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1［J］.Cancer Lett，2014，345(1)：39-47.
［18］Chen D，Yang H.Integrated analysis of differentially expressed genes in breast cancer pathogenesis［J］.Oncol Lett，2015，9(6)：2560-2566.
［19］Leivonen SK，Makela R，Ostling P，et al.Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines［J］.Oncogene，2009，28(44)：3926-3936.
［20］Yoshimoto N，Toyama T，Takahashi S，et al.Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer［J］.Breast Cancer Res Treat，2011，130(1)：331-339.
［21］Shigehara K，Yokomuro S，Ishibashi O，et al.Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer［J］.PLoS One，2011，6(8)：e23584.
［22］Shen R，Liyanarachchi S，Li W，et al.MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" Cases［J］.Thyroid，2012，22(1)：9-16.